Clinical Trial Update: Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis [NA]

View source ↗

Summary

This clinical trial update describes evaluating EGFR TKI resistance mechanisms in EGFR-mutant non-small cell lung cancer using plasma DNA analysis. The current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: EGFR Mutation Positive Non-small Cell Lung Cancer | NA | Status: UNKNOWN